Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

NCT00965250 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

Thymoma
Thymic Carcinoma
Thymic Carcinoid
Thymic Neuroendocrine Tumors

Interventions

DRUG: IMC-12

Sponsor

National Cancer Institute (NCI)